A case of pulmonary histoplasmosis treated with voriconazole

Authors

  • Congyi Xie Department of Pulmonary Medicine, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, Fujian, China
  • Yimin Yang Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China
  • Xiaodan Wu Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China
  • Zhangzhang Chen Department of Pharmacology, Zhongshan Hospital, Fudan University, Shanghai, China
  • Na Zhu Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China
  • Yuanlin Song Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China
  • Lin Tong Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China

DOI:

https://doi.org/10.3855/jidc.15297

Keywords:

Pulmonary histoplasmosis, voriconazole, immunosuppressive drugs

Abstract

Histoplasmosis is an infection caused by the dimorphic fungus Histoplasma capsulatum. The lungs are the most common site of infection, especially in patients with immune deficiency. We report a case of 62-year-old male patient presented with cough for 3 months and had been taking immunosuppressive drugs for 10 years after heart transplantation. Chest CT scan showed multiple pulmonary nodules. Lung tissue biopsy specimen culture suggested fungal infection, and Histoplasma capsulatum was confirmed by next-generation sequencing (NGS) detection. The patient was diagnosed with pulmonary histoplasmosis. After administration of voriconazole for 46 days, the symptom of cough was markedly relieved and the lesions were partly absorbed. After 13 months of treatment, the lesions completely disappeared, and no significant side-effect of voriconazole was observed. To our knowledge, report of voriconazole as the treatment of histoplasmosis is rare, especially in non-endemic areas. Moreover, this case enriches our experience in the adjustment between immunosuppressive and antifungal agents in treating histoplasmosis.

Downloads

Published

2022-03-31

How to Cite

1.
Xie C, Yang Y, Wu X, Chen Z, Zhu N, Song Y, Tong L (2022) A case of pulmonary histoplasmosis treated with voriconazole. J Infect Dev Ctries 16:570–574. doi: 10.3855/jidc.15297

Issue

Section

Case Reports